Malcolm Hoffman
Stock Analyst at BMO Capital
(1.61)
# 3,493
Out of 4,994 analysts
5
Total ratings
20%
Success rate
0.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Malcolm Hoffman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Reiterated: Buy | $310 | $203.10 | +52.63% | 3 | Sep 14, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $36 | $26.41 | +36.31% | 1 | Aug 24, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $46 | $42.69 | +7.75% | 1 | Jul 21, 2026 |
Axsome Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $310
Current: $203.10
Upside: +52.63%
ACADIA Pharmaceuticals
Aug 24, 2026
Reiterated: Buy
Price Target: $36
Current: $26.41
Upside: +36.31%
LB Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $42.69
Upside: +7.75%